Anti-cd20 therapy of ocular disorders

Details Anti-cd20 therapy of ocular disorders Anti-cd20 therapy of ocular disorders

A - Human Necessities

61

K

A61K 39/395 (2006.01) A61P 35/00 (2006.01) A61P 37/00 (2006.01) C07K 16/28 (2006.01)

Patent

CA 2535895

The present application describes therapy of ocular disorders using antagonists, such as antibodies, that bind to CD20.

La présente invention concerne le traitement de troubles oculaires au moyen d'antagonistes, tels que des anticorps, se liant à CD20.

Affiliated with

Also associated with

Rating

Anti-cd20 therapy of ocular disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-cd20 therapy of ocular disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-cd20 therapy of ocular disorders will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2003446